The Effect of Therapeutic Play Applied by Using Toy Nebulizer and Toy Mask on Child's Fear and Anxiety Level

NCT05415566 | Completed

• 1 other identifier: 21116
• Study Type: interventional
• Target: 84
• Locations: 1 country
• Sites: 1

Brief Summary

In this study, it was aimed to examine the effect of therapeutic play applied with a toy nebulizer and toy mask before inhaler treatment on children's fear and anxiety. It is the hypothesis of the study that the therapeutic play applied by using a toy mask and a toy nebulizer before inhaler treatment in children will reduce the child's fear and anxiety.

Conditions

Therapeutic Play; Anxiety; Fear

Keywords

Toy Mask; Toy Nebulizer; Child; Nurse

Outcome Measures

Primary Outcomes (2)

• Reducing the child's fear

  Reducing the child's fear during inhaler treatment

  during inhaler treatment

• Reducing the child's anxiety

  Reducing the child's anxiety during inhaler treatment

  during inhaler treatment

Secondary Outcomes (2)

• Reducing the "Child Fear Scale" score

  shortly after inhaler treatment

• Reducing the "Child Anxiety Scale-Stateness" score

  shortly after inhaler treatment

Study Arms (2)

Routine Treatment Group

NO INTERVENTION

Inhaler treatment was applied according to the routine procedure in the emergency department.

Therapeutic Play Group

EXPERIMENTAL

Inhaler treatment was applied according to the "Therapeutic Play Guide" prepared by the researcher.

Combination Product: toy nebulizer and toy mask

Interventions

toy nebulizer and toy mask COMBINATION_PRODUCT

The treatment was administered using therapeutic play.

Therapeutic Play Group

Eligibility Criteria

• Age: 3 Years - 8 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)

You may qualify if:

• Parent and child volunteering to participate in the study,
• The child is between the ages of 3-8,
• Being admitted due to respiratory system disease,
• Inhaler treatment with a nebulizer will be applied.

You may not qualify if:

• Parent and child not voluntarily participating in the study,
• Intravenous, intramuscular or any other treatment request,
• The child has any genetic, congenital, chronic or metabolic disease,
• The child has vision, hearing and speech problems,
• The child's vital signs are unstable (no fever, tachypnea, etc.) and the need for any emergency intervention.

Sponsors & Collaborators

• Ege University: lead

Study Sites (1)

Ege University

Izmir, Bornova, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: associate professor

Model Details: The population of the randomized controlled experimental study was composed of children aged 3-8 years who applied to the pediatric emergency department due to respiratory system disease.

Study Record Dates

• First Submitted: June 8, 2022
• First Posted: June 13, 2022
• Study Start: February 8, 2021
• Primary Completion: March 31, 2022
• Study Completion: June 3, 2022
• Last Updated: June 14, 2022

Record last verified: 2022-06

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)